National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings, 6333 [2013-01880]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with
Federal Register / Vol. 78, No. 20 / Wednesday, January 30, 2013 / Notices
Oak Campus.’’ Please note that visitors
to the White Oak Campus must enter
through Building 1.
Contact Person: Martha Monser,
Office of the Chief Scientist, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, rm. 4286,
Silver Spring, MD 20993, 301–796–
4627, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area). A notice in the Federal Register
about last minute modifications that
impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the Agency’s Web
site at https://www.fda.gov/
AdvisoryCommittees/default.htm and
scroll down to the appropriate advisory
committee meeting link, or call the
advisory committee information line to
learn about possible modifications
before coming to the meeting.
Agenda: On February 27, 2013, the
Science Board will be provided with
updates and/or draft reports from the
Center for Devices and Radiological
Health Research Review subcommittee
and the Global Health subcommittee. A
progress update will be presented
regarding the recently established
Center for Biologics Evaluation and
Review Post-Marketing Safety Review
subcommittee. An update on the plan to
establish a new subcommittee to
evaluate the Agency’s continuing work
to address the challenges identified in
Science Board’s 2007 ‘‘Science and
Mission at Risk’’ Report will be
presented. Plans will also be presented
and a proposed charge reviewed for a
second subcommittee to assess similar
issues with respect to information
technology including evaluation of
scientific data utilization, data
liberation and innovation. Overviews of
genomics activities at the Centers for
Food Safety and Applied Nutrition and
Veterinary Medicine will be presented,
along with plans for an Agency-wide
working group to address cross-cutting
genomics activities. Finally, recipients
of the FY2012 Scientific Achievement
awards (selected by the Science Board)
will provide overviews of the activities
for which the awards were given.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
VerDate Mar<15>2010
20:43 Jan 29, 2013
Jkt 229001
6333
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before Wednesday,
February 20, 2013. Oral presentations
from the public will be scheduled
between approximately 4:30 p.m. and 5
p.m. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before Tuesday, February 12, 2013.
Time allotted for each presentation may
be limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
Wednesday, February 13, 2013.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Martha
Monser at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 24, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
Dated: January 24, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–01944 Filed 1–29–13; 8:45 am]
[FR Doc. 2013–01880 Filed 1–29–13; 8:45 am]
BILLING CODE 4160–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; VSL
Fellowships.
Date: February 21, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd. Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders National Institutes of Health,
Rockville, MD 20850, 301–496–8693,
singhs@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Training
in Hearing Research Review Meeting.
Date: February 26, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders National Institutes of Health,
Rockville, MD 20850, 301–496–8683,
kellya2@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 78, Number 20 (Wednesday, January 30, 2013)]
[Notices]
[Page 6333]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01880]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; VSL Fellowships.
Date: February 21, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Blvd.
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D., Scientific Review Officer,
National Institute on Deafness and Other Communication Disorders
National Institutes of Health, Rockville, MD 20850, 301-496-8693,
singhs@nidcd.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; Training in Hearing
Research Review Meeting.
Date: February 26, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Andrea B. Kelly, Ph.D., Scientific Review
Officer, National Institute on Deafness and Other Communication
Disorders National Institutes of Health, Rockville, MD 20850, 301-
496-8683, kellya2@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: January 24, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-01880 Filed 1-29-13; 8:45 am]
BILLING CODE 4140-01-P
